Frontlight ResearchEarly access
Not yet taking people in FrancePhase 2
How well doxycycline reaches bone in people having hip replacement for osteoarthritis
Measures how much doxycycline reaches bone in adults having hip replacement surgery.
Key facts
- Who runs it
- Centre Hospitalier Universitaire De Caen Normandie
- Where
- Caen Cedex 9, FranceSee the site
- Trial code
- Registry title
- DOXYCYCLINE PENETRATION INTO BONE AND JOINT.
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 30 people, planned
- Started
- 1 Jun 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Interventional
- Record updated
- 20 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with hip osteoarthritis who are scheduled for a planned hip replacement. It measures how much doxycycline reaches the bone.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- Hip osteoarthritis (coxarthrosis) needing a planned total hip replacement. No infection.
- Earlier treatment
- No antibiotics within one month before the surgery.
Main reasons for not taking part
- Allergy to doxycycline, other tetracycline antibiotics or the tablet ingredients, or taking retinoids or vitamin A above 10,000 IU/day
- Past infection linked to hip prosthesis surgery, or an infection at the time of surgery
- Kidney failure with GFR < 60 mL/min/1,73m2, BMI < 21 kg/m2 or serum albumin < 30g/L
- Problems absorbing medicines by mouth, such as after sleeve surgery or colectomy, or taking antacids or oral iron
- Pregnant or breastfeeding women, or women before menopause without effective contraception
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age between 18 and 80 years old
- Scheduled for elective surgery for hip replacement due to coxarthrosis
- Signed informed consent
- Patients eligible for French social insurance; Participants able to fully understand the study and who accept its requirements and constraints
Who cannot take part
- Patient with a contraindication to surgical procedure
- Patient who has received antibiotics within one month prior to the procedure
- Patients with contraindications to doxycycline ( hypersensitivity to the active substance or to any of the excipients (particularly as generic formulations are authorized in the study and excipients may therefore differ), hypersensitivity to tetracycline-class antibiotics, co-administration of retinoids, or vitamin A supplementation exceeding 10,000 IU/day, due to the risk of intracranial hypertension and intestinal obstruction)
- history of osteoarticular infection related to hip prosthesis surgery
- Patient with an infection at the time of surgical management
- malabsorption syndrome or conditions likely to impair antibiotic absorption (sleevs, colectomy, gastrointestinal antacids (magnesium, aluminum, or calcium salts, oxides, or hydroxides) and oral iron salts……)
- Malnutrition patient (BMI < 21 kg/m2) or with serum albumin < 30g/L
- Kidney failure with GFR < 60 mL/min/1,73m2
- Women of childbearing age without effective contraception : childbearing age means non menopausal women. Effective contraception includes taking a contraceptive pill or using an Intra Uterine Device
- Patient who did not take Doxycycline as planned in the protocol
- Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators
- Patients unable to take oral doxycycline
- Pregnant or breastfeeding women
- Patients under guardianship, curatorship, legal protection or conservatorship
Where in France
- Centre Hospitalier Universitaire De Caen NormandieCaen Cedex 9, FranceNot yet recruiting
About the trial
What the trial wants to find out
The objective of this study is to provide robust data on bone penetration of the doxycycline in non-infected patient. The primary objective is to determine the penetration of doxycycline in cancellous bone.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- DOXYCYCLINE PENETRATION INTO BONE AND JOINT.
- Plain-language title
- How well doxycycline reaches bone in people having hip replacement for osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 20 July 2026